Unlocking Revenue: The Hidden Costs of Prior Authorization Delays

The introduction of electronic drug prior authorization (ePA) processes is reshaping the revenue cycle management (RCM) landscape, presenting both opportunities and challenges for healthcare organizations. RCM teams must adapt swiftly, as these changes can significantly impact operational efficiency and financial performance.

What's Actually Happening

The healthcare industry is witnessing a significant shift towards electronic drug prior authorization, driven by the need for greater efficiency and improved patient experiences. CERTIFY Pay has highlighted the potential benefits of this shift, indicating that ePA can streamline the prior authorization process for medications. By automating this critical step, healthcare providers and payers can reduce the time and resources spent on manual authorizations, which have historically caused delays in patient care.

Free Daily RCM Intelligence

Denial trends, payer policy moves, vendor intel — delivered every morning. Free.

Advertise with RevCycleAI

Reach RCM decision-makers daily.

Billing directors, VP Revenue Cycle, payor contracting leads.

Get the media kit →